A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT05076175
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Colitis, Ulcerative
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ozanimod — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to conventional therapy.
Key Dates
- Start date
- May 30, 2022
- Status verified
- Jun 2026
- Primary completion
- Jul 12, 2032
- Completion
- Jul 12, 2032
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Ozanimod High Dose
- Experimental: Ozanimod Low Dose
Primary Outcome Measure
Proportion of participants who achieve clinical remission [ Time Frame: At Week 52 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (36)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0041 | Phoenix | Arizona | 85016-7710 | - |
| University of Arizona | Tucson | Arizona | 85724 | - |
| Local Institution - 0052 | Garden Grove | California | 92845 | - |
| Loma Linda University Health System | Loma Linda | California | 92354 | Kalyan Ray Parashette, Site 0087 505-274-0704 |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Shervin Rabizadeh, Site 0074 310-423-7100 |
| Lucile Packard Children's Hospital | Palo Alto | California | 94304 | Jonathan Moses, Site 0080 650-721-2250 |
| University of California Davis Health | Sacramento | California | 95817 | Trinh Truong, Site 0096 310-597-1251 |
| Local Institution - 0007 | Hartford | Connecticut | 06106 | - |
| Local Institution - 0064 | Washington D.C. | District of Columbia | 20010 | - |
| Local Institution - 0075 | Orlando | Florida | 32803 | - |
| Local Institution - 0016 | Atlanta | Georgia | 30342 | - |
| Local Institution - 0101 | Park Ridge | Illinois | 60068 | Site 0101 |
| Local Institution - 0100 | Indianapolis | Indiana | 46202 | Site 0100 |
| Local Institution - 0049 | Iowa City | Iowa | 52242 | - |
| Maine Medical Partners | Portland | Maine | 04102 | Noah Hoffman, Site 0090 207-662-5522 |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Athos Bousvaros, Site 0005 617-699-1021 |
| Local Institution - 0042 | Springfield | Massachusetts | 01199 | - |
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01655 | Basavaraj Kerur, Site 0095 774-441-8082 |
| Local Institution - 0093 | Detroit | Michigan | 48201 | - |
| Mayo Clinic in Rochester, Minnesota | Rochester | Minnesota | 55905 | Michael Stephens, Site 0070 111111 |
| Washington University | St Louis | Missouri | 63110 | Charles Samson, Site 0053 513-518-8949 |
| Columbia University Medical Center | New York | New York | 10032 | JOSEPH PICORARO, Site 0040 212-305-5903 |
| Local Institution - 0023 | New York | New York | 10065 | - |
| Local Institution - 0028 | New York | New York | 10029 | - |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | 27599 | - |
| Local Institution - 0047 | Charlotte | North Carolina | 28203 | - |
| Cleveland Clinic | Cleveland | Ohio | 44124 | Jessica Barry, Site 0036 216444231 |
| Local Institution - 0062 | Oklahoma City | Oklahoma | 73112 | - |
| Local Institution - 0045 | Hershey | Pennsylvania | 17033 | - |
| Local Institution - 0099 | Charleston | South Carolina | 29425 | Site 0099 |
| Local Institution - 0103 | Fort Worth | Texas | 76104 | Site 0103 |
| Texas Children's Hospital | Houston | Texas | 77030 | Lina Karam, Site 0067 832-822-3612 |
| Local Institution - 0091 | Seattle | Washington | 98122 | - |
| Seattle Children's Hospital | Seattle | Washington | 98105 | Ghassan Wahbeh, Site 0060 111111 |
| MultiCare Health System | Tacoma | Washington | 98405 | Raghu Varier, Site 0046 503-847-4748 |
| Local Institution - 0037 | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsPHASE2 · Recruiting · University of California, San Diego · La Jolla, California
- Therapeutic Endpoint in Pediatric IBD ConditionsRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisRecruiting · Pfizer · Mesa, Arizona
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Bristol, Connecticut